Sara Santagata

842 total citations
19 papers, 602 citations indexed

About

Sara Santagata is a scholar working on Oncology, Immunology and Gastroenterology. According to data from OpenAlex, Sara Santagata has authored 19 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Immunology and 3 papers in Gastroenterology. Recurrent topics in Sara Santagata's work include Cancer Immunotherapy and Biomarkers (10 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (6 papers). Sara Santagata is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (6 papers). Sara Santagata collaborates with scholars based in Italy, Malaysia and Switzerland. Sara Santagata's co-authors include Stefania Scala, Caterina Ieranò, Maria Napolitano, Giuliana Lania, Delia Zanzi, Salvatore Auricchio, Maria Vittoria Barone, Anna Maria Trotta, Merlin Nanayakkara and Crescenzo D’Alterio and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Sara Santagata

19 papers receiving 593 citations

Peers

Countries citing papers authored by Sara Santagata

Since Specialization

Citations

This map shows the geographic impact of Sara Santagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Santagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Santagata more than expected).

Fields of papers citing papers by Sara Santagata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Santagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Santagata. The network helps show where Sara Santagata may publish in the future.

Co-authorship network of co-authors of Sara Santagata

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Santagata. A scholar is included among the top collaborators of Sara Santagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Santagata. Sara Santagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment 2023 ·Hepatology International ·Sara Santagata, Giuseppina Rea, (unknown), Maria Napolitano, (unknown), Crescenzo D’Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Salvatore Di Maro, Fabiana Tatangelo, Vittorio Albino, (unknown), Carmen Cutolo, Francesco Izzo, Stefania Scala	10
2	Abstract 2550: Tumor microenvironment (TME) is more suppressive in hepatocellular carcinoma (HCC) than in colorectal cancer liver metastasis (CRLM): CXCR4 antagonism as strategy to revert T regulatory cells (Tregs) suppressive activity 2022 ·Cancer Research ·(unknown), Sara Santagata, Giuseppina Rea, Maria Napolitano, Crescenzo D’Alterio, (unknown), Vittorio Albino, Andrea Belli, Carmen Cutolo, Francesco Izzo, Stefania Scala	1
3	CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment 2021 ·Frontiers in Oncology ·Sara Santagata, Caterina Ieranò, Anna Maria Trotta, (unknown), (unknown), (unknown), Stefania Scala	70
4	Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 2021 ·Journal of Medicinal Chemistry ·Anna Maria Trotta, Michela Aurilio, Crescenzo D’Alterio, Caterina Ieranò, (unknown), Antônio Barbieri, Antonio Luciano, (unknown), Sara Santagata, Luigi Portella, Stefano Tomassi, Luciana Marinelli, Deborah Sementa, Ettore Novellino, Secondo Lastoria, Stefania Scala, Margret Schottelius, Salvatore Di Maro	12
5	Abstract 6675: Basal NK activity and early Tregs inhibition predicts nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial 2020 ·Cancer Research ·Sara Santagata, Anna Maria Trotta, Giuseppina Rea, Maria Napolitano, (unknown), Crescenzo D’Alterio, Marilena Di Napoli, Sabrina Rossetti, Sandro Pignata, Stefania Scala	1
6	New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer 2020 ·Cancers ·Crescenzo D’Alterio, Antonella Zannetti, Anna Maria Trotta, Caterina Ieranò, Maria Napolitano, Giuseppina Rea, Adelaide Greco, Piera Maiolino, Sandra Albanese, Giosuè Scognamiglio, Fabiana Tatangelo, Salvatore Tafuto, Luigi Portella, Sara Santagata, Guglielmo Nasti, Alessandro Ottaiano, Roberto Pacelli, Paolo Delrio, Gerardo Botti, Stefania Scala	17
7	Basal NK activity and early Treg function inhibition predicts Nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial 2019 ·Annals of Oncology ·Sara Santagata, Anna Maria Trotta, Giuseppina Rea, Maria Napolitano, Crescenzo D’Alterio, Marilena Di Napoli, Sabrina Rossetti, Sandro Pignata, Stefania Scala	1
8	Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity 2018 ·Journal of Experimental & Clinical Cancer Research ·Anna Maria Trotta, Sara Santagata, Serena Zanotta, Crescenzo D’Alterio, Maria Napolitano, Giuseppina Rea, Rosa Camerlingo, (unknown), (unknown), (unknown), Gerardo Botti, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala	18
9	A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors 2017 ·Scientific Reports ·Sara Santagata, Luigi Portella, Maria Napolitano, Adelaide Greco, Crescenzo D’Alterio, Maria Vittoria Barone, Antonio Luciano, Matteo Gramanzini, Luigi Auletta, Claudio Arra, Antonella Zannetti, Stefania Scala	18
10	Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer 2017 ·Oncotarget ·Sara Santagata, Maria Napolitano, Crescenzo D’Alterio, (unknown), Salvatore Di Maro, Luciana Marinelli, Alessandra Fragale, Maria Buoncervello, Francesco Persico, Lucia Gabriele, Ettore Novellino, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala	68
11	Abstract 580: Nivolumab treatment of metastatic renal cancer patients impairs Tregs and potentiates NK function: The role of CXCR4 inhibition (“REVOLUTION Trial”) 2017 ·Cancer Research ·Sara Santagata, Anna Maria Trotta, Maria Napolitano, Luigi Portella, Sabrina Rossetti, Sisto Perdonà, Sandro Pignata, Stefania Scala	1
12	Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach 2017 ·Oncotarget ·Davide Gentilini, Stefania Scala, Germano Gaudenzi, Paolo Garagnani, Miriam Capri, Matteo Cescon, Gian Luca Grazi, Maria Giulia Bacalini, (unknown), Alessandra Dicitore, Luisa Circelli, Sara Santagata, Francesco Izzo, Anna Maria Di Blasio, Luca Persani, Claudio Franceschi, Giovanni Vitale	47
13	CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients 2016 ·OncoImmunology ·Crescenzo D’Alterio, Guglielmo Nasti, (unknown), Alessandro Ottaiano, Manuel Conson, Luisa Circelli, Gerardo Botti, Giosuè Scognamiglio, Sara Santagata, Chiara De Divitiis, Anna Nappi, Maria Napolitano, Fabiana Tatangelo, Roberto Pacelli, Francesco Izzo, Emilia Vuttariello, Stefania Scala	39
14	CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells 2014 ·Cell Death and Disease ·Caterina Ieranò, Sara Santagata, Maria Napolitano, (unknown), Anna Grimaldi, (unknown), Gerardo Botti, Claudia Consales, Anna Riccio, Merlin Nanayakkara, Maria Vittoria Barone, Michele Caraglia, Stefania Scala	74
15	Immunoregulatory Pathways Are Active in the Small Intestinal Mucosa of Patients with Potential Celiac Disease 2013 ·The American Journal of Gastroenterology ·Melissa Borrelli, V.M. Salvati, Mariantonia Maglio, Delia Zanzi, (unknown), Sara Santagata, (unknown), Rosita Aitoro, Giuseppe Mazzarella, Giuliana Lania, Carmen Gianfrani, Renata Auricchio, Riccardo Troncone	28
16	Gliadin-Mediated Proliferation and Innate Immune Activation in Celiac Disease Are Due to Alterations in Vesicular Trafficking 2011 ·PLoS ONE ·Maria Vittoria Barone, Delia Zanzi, Mariantonia Maglio, Merlin Nanayakkara, Sara Santagata, Giuliana Lania, Erasmo Miele, M. Ribecco, Francesco Maurano, Renata Auricchio, Carmen Gianfrani, Silvano Ferrini, Riccardo Troncone, Salvatore Auricchio	57
17	IL-15 Interferes With Suppressive Activity of Intestinal Regulatory T Cells Expanded in Celiac Disease 2011 ·The American Journal of Gastroenterology ·Delia Zanzi, Rosita Stefanile, Sara Santagata, Laura Iaffaldano, Gaetano Iaquinto, Nicola Giardullo, Giuliana Lania, (unknown), (unknown), (unknown), Salvatore Auricchio, Riccardo Bonfanti, Giuseppe Mazzarella	85
18	Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation 2010 ·PLoS ONE ·Maria Vittoria Barone, Merlin Nanayakkara, Giovanni Paolella, Mariantonia Maglio, (unknown), (unknown), M. Ribecco, Giuliana Lania, Delia Zanzi, Sara Santagata, Renata Auricchio, Riccardo Troncone, Salvatore Auricchio	54
19	PP22 GLIADIN PEPTIDE P31-43 ENHANCES IL15 ACTIVITY BY INTERFERING WITH ITS INTRACELLULAR TRAFFICKING 2010 ·Digestive and Liver Disease ·Sara Santagata, Delia Zanzi, Mariantonia Maglio, Merlin Nanayakkara, Giuliana Lania, Valentina Discepolo, Roberta Kosova, Katherine W. Ferrara, (unknown), (unknown), (unknown), Riccardo Troncone, Salvatore Auricchio, Maria Vittoria Barone	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact